toate categoriile

Acasă>Produse>Produse farmaceutice finite>Cardiovasculare și urinare

Injecție cu acid tranexamic


Detaliu rapid:




Suport OEM/ODM:Da

MOQ:500,000 Amps

Timp de livrare:30 ~ 55 Zile

termen comerț:FOB, CIF

Termen de plata:T / T, L / C

Standard disponibil:CP,BP

Documente:GMP, CPP, FSC, CTD



1. This product is primarily used for all types of bleeding due to acute or chronic, limited or systemic primary fibrinolysis. It is generally not used in secondary hyperfibrinolytic states caused by disseminated intravascular coagulation prior to heparinization.

2. For trauma or surgical bleeding in fibrinogen-rich organs such as prostate, urethra, lung, brain, uterus, adrenal gland and thyroid.

3. Used as an antagonist of tissue-type fibrinogen activator (t-PA), streptokinase and urokinase.

4. For fibrinolytic bleeding due to miscarriage, early placental abruption, stillbirth and amniotic fluid embolism, and increased menorrhagia due to localized fibrinolytic lesions in the uterine cavity.


Reacții adverse

1. Occasionally, there is intracranial thrombosis and bleeding due to drug overdose.

2.There may be diarrhea, nausea, and vomiting.

3.Less commonly, there is menstrual discomfort (due to blood clotting during menstruation).4 Because the product can enter the cerebrospinal fluid, central nervous system symptoms such as blurred vision, headache, dizziness, and fatigue may occur after injection, especially in relation to the rate of injection, but are rare.





A se păstra într-un loc răcoros, uscat și întunecat.

Păstrați toate medicamentele departe de copil.